[Antidote to dabigatran].
Thorsten
T
Steiner
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D000069604:Dabigatran; D006470:Hemorrhage / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D012307:Risk Factors; D013927:Thrombosis / Q000517:prevention & control*; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors
D061067:Antibodies, Monoclonal, Humanized; D001562:Benzimidazoles; D015091:beta-Alanine; C000594745:idarucizumab; D000069604:Dabigatran